Sponsored Research And Training Grants:

2009 - 2010

The current research and training grants of the faculty and fellows in the Weill Cornell Division of International Medicine and Infectious Diseases are noted below. There are opportunities for fellows to participate in these research projects, as well as with investigators at Rockefeller University and at Sloan-Kettering Institute.

  1. AIDS International Training and Research Program. WD Johnson. NIH D43 TW00018. 1989-2013.
  2. Pathogenesis of Infectious Diseases Training. WD Johnson. NIH T32 AI07613. 1999-2014.
  3. Caribbean HIV/AIDS Regional Training/CHART Initiative (I-TECH). WD Johnson. HRSA UW U69HA00047. 2004-2010.
  4. Haiti Research Training: Models to Implementation (ICOHRTA). WD Johnson. NIH U2R TW06901. 2004-2010.
  5. Framework Program for Global Health. WD Johnson. NIH R25 TW007736. 2006-2010.
  6. Pathogenesis of Leishmaniasis: Host, Parasite and Vector - Tropical Medicine Research Center (TMRC). E Carvalho, WD Johnson. NIH P50 AI30639. 1991-2012.
  7. Clinical Trials for HIV Infection and HIV-Related Diseases. MJ Glesby, RM Gulick, K Marks, M Vogler, TJ Wilkin. Multiple Sources. 1999-2011
  8. NY/NJ AIDS Education and Training Center (AETC). MJ GLesby, RM Gulick, Health Research Services Administration (HRSA), CU H4A HA00071. 2002-2010
  9. The Women's Interagency HIV Study (WIHS). MJ Glesby. NIH U01 AI35004. 2003-2012.
  10. Growth Hormone and/or Rosiglitazone for Visceral Adiposity in HIV. MJ Glesby. NIH R01 DK065515. 2004-2010.
  11. Multiplexed Detection of Food and Waterborne Pathogens. F Barany, LM Golightly, D Larone. NIH U01 AI075470. 2007-2012.
  12. Weill Cornell Clinical Trials Unit (ACTU). RM Gulick, MJ Glesby, K Marks, M Vogler, TJ Wilkin. NIH U01 AI69419. 2007-2013.
  13. Antiretroviral Therapy. Mid-Career Investigator Award in Patient-Oriented Research. RM Gulick, NIH K24 AI51966. 2003-2008.
  14. Antigen Capture Assays for Rapid Tuberculosis Diagnosis. JL Ho, NIH R21 AI062332. 2004-2007.
  15. Large Scale Gene Deletion in Infectious M. tuberculosis. JL Ho, NIH R21 AI063147. 2005-2007.
  16. CFP32-Based Point-Of-Care Tuberculosis Diagnosis. JL Ho, World Health Organization. 2006-2008.
  17. Production of M. tuberculosis Proteins by Yeast and Bacillus Calmette Guerin to Enhance the Sensitivity of TB Serodiagnostic Assay. JL Ho, Foundation for Innovative New Diagnostics (Bill & Melinda Gates Foundation).
  18. Outer Membrane Proteins of Pathogenic Leptospira Species. DA Haake, AI Ko, NIH RO1 AI03443. 2003-2012. AI Ko NIH RO1 AI052473. 2003-2008.
  19. Natural History of Leptospirosis. AI Ko, NIH RO1 AI052473. 2003-2014.
  20. Emerging Infectious Diseases and Urbanization. AI Ko, WD Johnson. NIH D43 TW00919. 1997-2010.
  21. Transmission of Drug-Resistant Streptococcus Pneumoniae in Brazil. JN Reis AI Ko, NIH R01 TW007303. 2005-2010.
  22. Rapid Serodiagnostic Test for Leptospirosis. K Lyashchenko, AI Ko, NIH R43-AI072856. 2007-2012.
  23. Thrombocytopenia and HIV/HCV: Risk Factors and Treatment. K Marks, NIH K23 AI065319. 2005-2010.
  24. Immunoregulation of Responsiveness to Chemotherapy in Visceral Leishmaniasis: Optimizing the Host Response Treatment. HW Murray, NIH 2RO1/R56 AI16963. 2001-2010.
  25. Tropical Medicine Research Center: Visceral Leishmaniasis in Bihar State, India. S Sundar, HW Murray. NIH P50 AI074321. 2007-2012
  26. Innate Immune Responses to Adenoviral Vectors. M Nociari. NIH K01 HL 70438. 2002-2007.
  27. International Clinical Trials Unit (CTU). JW Pape, RM Gulick, MJ Glesby, DW Fitzgerald, WD Johnson, NIH U01 AI069421-01. 2006-2013.
  28. Comprehensive International Program of Research on AIDS (CIPRA). JW Pape, WD Johnson, DW Fitzgerald. NIH UO1 AI010018. 2003-2010.
  29. Haiti Research Training: Models to Implementation (ICOHRTA). JW Pape, NIH U2R TW06901. 2004-20014.
  30. Strengthening and Expanding Antiretroviral Treatment in the Republic of Haiti to HIV/AIDS Infected Populations through Training, Support and Quality Assurance/Quality Control at Antiretroviral Sites as Part of the President's Emergency Plan for AIDS Relief. JW Pape, Centers for Disease Control and Prevention. 2005-2010.
  31. Enzymes of Intermediary Metabolism in Mycobacterium tuberculosis: Anti-Mycobacterial Targets of Nitric Oxide. KY Rhee, Burroughs Wellcome Career Award in the Biomedical Sciences. 2005-2010.
  32. Vancomycin-induced heteroresistance among S. aureus isolates in recipients of hemodialysis. KY Rhee. Cubist Pharmaceuticals.
  33. Applied Research in Antimicrobial Resistance: Studies of Susceptibility Testing on Gram-negative Multidrug Resistant Organisms. KY Rhee (Co-PI), L Saiman (PI). NIH R01CI000537. 2007-2010.
  34. Complications of Chronic Viral Infections. Mid-Career Investigator Award in Patient-Oriented Research. MJ GLESBY K24AI078884 2008-2013
  35. Fogarty International Clinical Research Scholars Program. The Salvador, Brazil Training Program for Tropical Disease Research. MJ GLESBY, EM CARVALHO, AI KO, WD JOHNSON. 2009-2011
  36. Immunological response, Viral Factors and Helminth Infections in Diseases Expressi. E. Carvalho. NIAID 1R01AI079238. 2009-2013
  37. AIDS International Training and Research Program. WD. Johnson. NIH D43TW000018-22S1. 2009-2011.
  38. AIDS International Training and Research Program. WD. Johnson. NIH D43TW000018-22S2. 2009-2010.
  39. Haiti AIDS Research Training: Models to Implementation. WD. Johnson. NIH U2RTW006901-05S1. 2009-2010.

CONTACT US

Infectious Diseases

Kristen Marks, MD, Program Director
Leyla Pistone, Program Coordinator
Room: A-421
Tel: (212) 746-7587
Fax: (212) 746-8675
[email protected]

Top of page